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Abstract
Background: Creutzfeldt–Jakob disease is a rare and rapidly fatal neurodegenerative disease. Since clinicians may
see only very few cases during their professional career, it is important to be familiar with the clinical presentation
and progression, to perform appropriate investigations, and allow for quick diagnosis.
Case presentation: A 73-year-old British Caucasian woman presented with acute confusion of 2 weeks’ duration
on a background of low mood following a recent bereavement. Her symptoms included behavioral change, visual
hallucinations, vertigo, and recent falls. She was mildly confused, with left-sided hyperreflexia, a wide-based gait,
and intention tremor in her left upper limb. Initial blood tests, computed tomography, and magnetic resonance
imaging of her brain showed no significant abnormality. Following admission, she had rapid cognitive decline and
developed florid and progressive neurological signs; a diagnosis of prion disease was suspected. A lumbar puncture
was performed; cerebrospinal fluid was positive for 14–3-3 protein, real-time quaking-induced conversion, and
raised levels of s-100b proteins were detected. An electroencephalogram showed bilateral periodic triphasic waves
on a slow background. The diagnosis of probable Creutzfeldt–Jakob disease was made.
Conclusions: This case report highlights key features in the initial presentation and clinical development of a
rare but invariably rapidly progressive and fatal disease. It emphasizes the importance of considering a unifying
diagnosis for multifaceted clinical presentations. Although it is very rare, Creutzfeldt–Jakob disease should be
considered a diagnosis for a mixed neuropsychiatric presentation, particularly with rapid progressive cognitive
decline and development of neurological signs. However, to avoid overlooking early signal change on magnetic
resonance imaging, it is important to take diffusion-weighted magnetic resonance imaging for all patients with
neuropsychological symptoms. Importantly, early diagnosis also ensures the arrangement of suitable contamination
control measures to minimize the risk of infection to health care professionals and other patients.
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Background
Creutzfeldt–Jakob disease (CJD) is a rare neurodegenera-
tive disease caused by a misfolding of a host protein called
a prion protein (PrP). When a pathologically misfolded
PrP (PrPSc) is formed, it acts as a seed for the misfolding
of normal cellular PrP (PrPC). This causes a chain reaction
which leads to cell death and the manifestations of the dis-
ease [1]. Most commonly it occurs sporadically (sCJD),
but may also be genetic or variant (acquired) in etiology.
All forms are rapidly progressive and invariably fatal, with
sCJD affecting 1 to 2 per million people per year world-
wide [2]. As PrP is most abundant in neurons, the early
manifestations are neurological [1].
Neither a cure nor disease-modifying treatments exist
for suspected cases of CJD. However, early suspicion
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facilitates relevant diagnostic investigations, allowing for
discussion with patients, family, and a specialist clinical
unit in a timely manner and for supportive management.
Specific infection control procedures should be put in
place for all invasive procedures when CJD is suspected
as a potential diagnosis [3]. Case detection is vital in
disease surveillance and monitoring; case detection is
also important for research into improving diagnosis and
toward future treatment. Reviewing this case, the
presentation and clinical progression corroborated with
many other cases documented in the literature. How-
ever, the diagnosis was not initially suspected, perhaps
because most physicians do not encounter a case in the
entirety of their career and many of the symptoms are
nonspecific: a depressive prodrome, memory loss, and
acute confusion are common in the elderly on the acute
medical take, and the differential for cerebellar signs is
broad. The rapid progression of neurological signs may
increase suspicion of a potential diagnosis of CJD.
This could be considered a good example of the Law of
Diagnostic Parsimony (Occam’s razor): although multifac-
torial causes of presenting complaints are common in the
elderly, sometimes there is just one underlying diagnosis
to account for all symptoms.
Case presentation
Our patient, a previously well and independent 73-year-old
Caucasian woman, presented to our Emergency depart-
ment (ED) with subacute onset confusion. Her family re-
ported worsening confusion in the preceding 2 weeks,
which was associated with behavioral changes that were
mainly related to visual hallucinations, waking up at night
and talking to herself, looking for her late sister, and think-
ing that there were men around her bed. She had started
experiencing vertigo and had fallen at home 2 weeks prior
to admission, although she denied associated head injury.
The onset of symptoms reportedly coincided with a family
bereavement and our patient had recently been restarted
on antidepressants by her general practitioner (GP) due to
pervasive low mood. She had no infective symptoms. Her
past medical history included hypertension, depression,
and anxiety. Prior to admission, she lived alone and inde-
pendently, with no concerns regarding cognition. She was
taking prochlorperazine (vertigo), doxazocin, and paroxe-
tine (depression) confirmed by her GP and Pharmacy
medicines reconciliation; she denied any other previous or
current drug or alcohol use and this was corroborated by
her family. She did not smoke tobacco. She had no signifi-
cant familial history and no children.
On admission she appeared alert, Glasgow Coma Scale
(GCS) 15/15. Her Abbreviated Mental Test score (AMTS)
on admission was 9/10. She was moderately hypertensive
(160/63), with all other observations within normal range.
Cardiovascular, respiratory, and abdominal examinations
were unremarkable. However, abnormalities were seen on
neurological examination. She appeared unsteady on
standing with a wide-based gait, falling to the left side on
attempted mobilization. Reflexes in her lower limbs were
noted to be brisk (left>right) and on examination of her
upper limbs there was left-sided intention tremor,
dysdiadochokinesis, and past-pointing. Overall it was a
predominantly cerebellar picture, with some upper motor
neuron features.
Initial investigations were grossly normal (see below);
she was admitted to our medical ward for further observa-
tion and investigations. During initial admission, a broad
range of concurrent differential diagnoses were suggested
to account for her recent behavioral changes and ataxia.
On admission, blood tests showed a mildly raised
C-reactive protein (CRP) of 9.8 mg/L and mildly raised
urea; otherwise a full blood count (FBC), urea and electro-
lytes (U&Es), bone profile, liver function tests (LFTs), and
thyroid function tests (TFTs) were all within normal range.
Specifically: white cell count (WCC) 6.0 × 109/L (reference
range 3.8–10.8), hemoglobin (Hb) 126 g/L (117–155),
platelets 220 × 109/L (140–400), sodium (Na) 135 mmol/L
(136–146), potassium (K) 4.1 (3.5–5.1), creatinine 73
umol/L (45–84), urea 9.0 mmol/L (2.8–7.2), calcium (Ca)
2.42 mmol/L (2.2–2.65), inorganic phosphate 1.14 mmol/L
(0.81–1.45), and alkaline phosphatase (ALP) 98 IU/L (30–
120); albumin 40 g/L (35–52) and CRP 9.8 mg/L (0–7.9).
A urine dipstick was negative and there was no growth
from a midstream urine (MSU) test. A chest X-ray (CXR)
revealed no abnormality. A computed tomography (CT)
scan of her head showed no acute intracranial abnormality.
On the initial magnetic resonance imaging (MRI) report, a
few small nonspecific white matter lesions were noted, no
intracranial abnormality correlating with our patient’s
symptoms was identified. No comment was made on the
thalamus or basal ganglia. Following later specialist review,
this MRI scan was thought to be consistent with prion dis-
ease, with bilateral symmetrically increased signal intensity
in the basal ganglia on T2-weighted imaging (Fig. 1).
Electroencephalography (EEG) showed a background
of intermixed delta activity at rate 2.5–3.9 Hz and theta
activity at rate 4–5.5 Hz bilaterally through all channels,
interrupted by prolonged runs of anteriorly dominant
widespread triphasic waves – bilateral independent
periodic lateralized epileptiform discharges (BiPLEDs) –
occurring at 1–2 Hz and lasting from several seconds to
a few minutes. These findings were reported as suggest-
ive of bilateral cerebral/cortical dysfunction, with pos-
sible causes including prion disease, viral encephalitis,
metabolic, and vascular.
A lumbar puncture was performed with the following re-
sults: cytology – no cells identified; viral polymerase chain
reaction (PCR) – herpes simplex virus (HSV) deoxyribo-
nucleic acid (DNA), varicella zoster virus (VZV) DNA,
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enterovirus RNA not detected; oligoclonal bands – cere-
brospinal immunoglobulin G (IgG) 32 mg/L (10–40); cere-
brospinal fluid (CSF) protein 0.5 g/L (reference range
0.15–0.8); and CSF glucose 3.8 mmol/L (2.2–3.9). A CSF
sample was sent to the National CJD Research & Surveil-
lance Unit (NCJDRSU) in Edinburgh, which was found to
be positive for 14–3-3 protein and real-time quaking-
induced conversion (RT-QuIC) was positive. Raised levels
of s-100b protein > 2.5 ng/mL (reference range < 0.41 ng/
mL) were detected.
A definitive diagnosis of CJD is neuropathological, re-
quiring brain biopsy or post-mortem analysis. Our pa-
tient’s family did not consent to post-mortem analysis
and declined further genetic testing for familial CJD.
Within weeks following her admission to the ward, she
underwent a rapid clinical deterioration. After 2 weeks she
was unable to follow simple verbal commands, with wors-
ening hypertonia bilaterally (although always more marked
on the left than the right). There was difficulty following
simple instructions and speech became slower and more
fragmented. She developed abnormal eye movements, with
hypometric saccades and impersistence of gaze. Her left
arm was noted to be akinetic with abnormal posturing and
spontaneous myoclonus, as well as hyperreflexia.
A month following admission, she was akinetic, mute,
and unresponsive to external stimuli. She had extensive
secretions requiring suctioning and was nasogastric tube
fed with high risk of aspiration. Following discussion
with her family and the palliative care team, a decision
was made to start a compassionate care agreement and
she died the following week.
Discussion and conclusions
Our patient’s initial presentation was a complex and
mixed neuropsychiatric picture. During her clerking,
common causes were considered to account for each
symptom individually (an application of Hickam’s dic-
tum: it is often more likely that a patient has several
common diseases rather than having a single rare dis-
ease to explain a myriad of symptoms). Frequent causes
of confusion in the elderly – infection, drug/alcohol in-
toxication or withdrawal, metabolic or vascular – were
all investigated with blood tests and scans and a psych-
iatry opinion sought relating to her known diagnosis of
depression. Common causes of cerebellar symptoms –
alcohol use, vascular – were appropriately investigated.
However, our patient’s family did not report an alcohol
history, and many of the differentials explored would
not have accounted for all of her psychiatric, cognitive,
and neurological symptoms.
Following admission, she was started empirically on
acyclovir for herpes simplex encephalitis. Following EEG,
this was still considered a differential but the neurological
signs seen here would have been an unusual presentation.
In addition, the CSF did not support this diagnosis.
With EEG and specialist interpretation of the MRI, CJD
was the most likely diagnosis to account for all of her
symptoms. Probable diagnosis of sCJD was further con-
firmed with supporting CSF findings: positive for 14–3-3
protein, raised protein levels of s-100b > 2.5 ng/mL (refer-
ence range < 0.41 ng/mL), and a positive RT-QuIC. The
clinical review by the NCJDRSU further supported the
diagnosis. It should be noted that in practice, the most
commonly used clinical criteria for probable sCJD do not
help with early diagnosis of CJD as akinetic mutism
and the characteristic EEG changes often do not
occur until late stages of the illness [4]. Furthermore,
the evidence to support use of ancillary tests (such as
EEG and CSF 14–3-3 protein) is mixed. Such tests have
been demonstrated to have poor sensitivity and/or specifi-
city and are often not useful in clinical practice [5].
CJD has attracted extensive scientific and public inter-
est due to its rare pathogenicity and notorious media
coverage of the variant form (vCJD); however, the
incidence is very low and early symptoms are often non-
specific, leading to frequent delay in appropriate
investigations and diagnosis. Initial presentation may be
psychiatric, neurological, or mixed; this patient’s psychi-
atric prodrome followed by rapid development of neuro-
logical symptoms is corroborated by other case reports
[6, 7]. The first symptom of CJD is usually rapidly pro-
gressive dementia, leading to memory loss, personality
changes, and hallucinations. When considering a rapidly
progressive dementia, particularly a patient with pro-
minent motor and/or cerebellar dysfunction, CJD should
be high on the list of differential diagnoses [8].
Fig. 1 Magnetic resonance image of the patient during admission.
T2-weighted magnetic resonance image showing bilateral
symmetrically increased signal intensity in the basal ganglia (red arrows)
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Previously, sCJD has been characterized by prominent
neurological symptoms, with vCJD more psychiatric in
presentation and course. However, a retrospective review
of 126 cases of sCJD found that 80% of cases demon-
strated psychiatric symptoms (depression, anxiety, psych-
osis, behavior change, sleep disturbance) within the first
100 days of illness, with 26% occurring at presentation [9].
Psychiatric manifestations may be an early and prominent
feature of sCJD, often occurring prior to formal diagnosis;
however, as in this case, psychiatric manifestations may be
misattributed to more common mood disorders or other
causes of cognitive impairment in the elderly. Other less
common initial presentations such as the Heidenhain
visual variant have also been reported [10].
sCJD is classified according to the following inter-
nationally recognized criteria updated in 2010, although
further modifications have been proposed [11]:
 Possible – rapidly progressive dementia plus two of:
myoclonus, visual or cerebellar problems, pyramidal/
extrapyramidal features, akinetic mutism.
 Probable – meets possible criteria plus one or more
of: typical EEG, high signal in caudate/putamen on
MRI or positive 14–3-3 protein in CSF.
 Definite – neuropathological or
immunohistochemical confirmation.
This case was probable, with a rapidly progressive de-
mentia and all other associated symptoms as well as
MRI, EEG, and CSF abnormalities (no neuropathology
specimen). Characteristic brain MRI lesion patterns are
the most recent addition to these criteria and are helpful
in establishing a diagnosis of sCJD, with high sensitivity
and specificity for the disease [12]. However, a major
limitation is that CJD-associated MRI changes are often
not documented on the formal investigation report from
the referring center. A recent study by the National
Prion Centre found that specialists were able to identify
sCJD-associated MRI changes in 83/91 cases (91%
sensitivity), whereas referring centers documented CJD-
associated MRI changes in 43 of the cases (47% sensitivity)
[13]. In this case, the possibility of prion disease was not
raised on the initial MRI request and not reported by a
non-specialist. Specialist review by an experienced neuro-
radiologist or prion disease specialist unit could facilitate
more rapid diagnosis. CT may reveal evidence of mild
brain atrophy in some cases but this remains uncommon
due to the speed of onset of CJD.
Almost all cases of CJD show altered EEG signals.
Slow wave activity remains constant and deteriorates
with the progression of the disease. Pseudo-periodic
sharp wave complexes of 1 Hz are characteristic of EEG
in cases of sCJD [14]. The presence of protein 14–3-3 is
also a specific finding, particularly concomitant with
EEG changes. A positive RT-QuIC and raised s-100b
protein levels further support the diagnosis of probable
CJD [15]. Although new tests have greatly enhanced the
sensitivity and specificity of diagnosing CJD, other CSF
biomarkers are currently being investigated [1, 16].
Case reports such as this are vital in raising awareness
of the clinical presentation and course of this rare
neurodegenerative disorder. Clinical suspicion facilitates
appropriate investigations and referral to the NCJDRSU,
guiding further management and research. In particular,
scientific and clinical advances in disease-modifying treat-
ment requires cases to be detected before they become
clinically advanced. Although early diagnosis does not
alter the outcome of the disease, it allows clinicians to ini-
tiate early advance care planning (ACP) discussions with
patients and their families. There is generally a low public
awareness but a high expressed willingness to engage in
an ACP discussion [17]. ACP can facilitate the delivery of
care more in keeping with a patient’s wishes and increase
patient and family satisfaction with care [18].
In a previously well patient presenting with a myriad
of new-onset signs and symptoms, it is vital to remem-
ber Occam’s razor and consider a unifying diagnosis.
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